Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Smits, Kim M" or (type exact bookEditor and editor="Smits, Kim M")

Add to list
Analysis of DNA methylation in cancer : location revisited

Alexander Koch, Sophie C Joosten, Zheng Feng, Tim C de Ruijter, Muriel X Draht, Veerle Melotte, Kim M Smits, Jurgen Veeck, James G Herman, Leander Van Neste, et al.

(2018) NATURE REVIEWS CLINICAL ONCOLOGY. 15(7). p.459-466
Add to list
A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients

Iris JH van Vlodrop, Sophie C Joosten, Tim De Meyer (UGent) , Kim M Smits, Leander Van Neste (UGent) , Veerle Melotte, Marcella MLL Baldewijns, Leo J Schouten, Piet A van den Brandt, Jana Jeschke, et al.

(2017) CLINICAL CANCER RESEARCH. 23(8). p.2006-2018
Add to list
- Journal Article
- A1
PET imaging of zirconium-89 labelled cetuximab : a phase I trial in patients with head and neck and lung cancer

Judith van Loon, Aniek JG Even, Hugo JWL Aerts, Michel Öllers, Frank Hoebers, Wouter van Elmpt, Ludwig Dubois, Anne-Marie C Dingemans, Roy I Lalisang, Pascal Kempers, et al.

(2016) RADIOTHERAPY AND ONCOLOGY. 122(2). p.267-273
Add to list
Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 are promising markers for the detection of colorectal cancer in blood

Veerle Melotte, Joo Mi Yi, Marjolein HFM Lentjes, Kim M Smits, Leander Van Neste, Hanneke EC Niessen, Kim AD Wouters, Joost Louwagie, Kornel E Schuebel, James G Herman, et al.

(2015) CANCER PREVENTION RESEARCH. 8(2). p.157-164
Add to list
- Journal Article
- A1
- open access
Emerging evidence for CHFR as a cancer biomarker : from tumor biology to precision medicine

Sarah Derks, Arjen HG Cleven, Veerle Melotte, Kim M Smits, Johann C Brandes, Nilofer Azad, Wim Van Criekinge (UGent) , Adriaan P de Bruïne, James G Herman and Manon van Engeland

(2014) CANCER AND METASTASIS REVIEWS. 33(1). p.161-171

Academic Bibliography

Analysis of DNA methylation in cancer : location revisited

A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients

PET imaging of zirconium-89 labelled cetuximab : a phase I trial in patients with head and neck and lung cancer

Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 are promising markers for the detection of colorectal cancer in blood

Emerging evidence for CHFR as a cancer biomarker : from tumor biology to precision medicine

Contents

Support

Contact